STAMFORD, Conn., Nov. 04, 2023 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating Stoke Therapeutics, Inc. (NASDAQ: STOK) (“Stoke” or the “Company”) on behalf of the Company’s investors.

The subject of this investigation is to determine whether Stoke’s board of directors (the “Board”) violated fiduciary duties owed to Stoke stockholders in connection with certain provisions in Stoke’s bylaws that may have the effect of entrenching the Board and insulating Stoke’s directors from being held accountable by Stoke stockholders.

Stoke stockholders are encouraged to contact Abbott Cooper PLLC by calling (475) 333-0674, emailing ac@abbottlawyer.com or visiting our website at www.abbottlawyer.com for additional information about this investigation as well as their legal rights and options.

Abbott Cooper PLLC is dedicated to shareholders’ rights and empowering shareholders through strategic counsel and legal advocacy. For additional information about Abbott Cooper PLLC, please visit www.abbottlawyer.com.

CONTACT:

Abbott Cooper PLLC
J. Abbott R. Cooper, Esq.
(475) 333-0674
www.abbottlawyer.com

Attorney advertising. Prior results do not guarantee a similar outcome.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.